US EMS Protocol Census
Statewide

Michigan Department of Health & Human Services, Bureau of Emergency Preparedness, EMS and Systems of Care

May be outdated61 dose entries28 drugs1 documentMIeffective 2023-01-0195% machine-parsed of 61

Michigan Department of Health & Human Services, Bureau of Emergency Preparedness, EMS and Systems of Care (MI) carries 28 drugs across 61 dose entries in its current published protocol, effective 2023-01-01.

The current listed document is more than 24 months old and may be outdated.

Drugs and doses28

Acetaminophen

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 800 mg PO not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27
Other peds 44.8 mg PO not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27

Adenosine

IndicationPopulationDoseRouteRepeatStandingSource
SVT adult 6 mg IV/IO not captured standing pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26
SVT peds 0.1 mg/kg IV/IO not captured standing pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26

Albuterol

IndicationPopulationDoseRouteRepeatStandingSource
Asthma / bronchospasm adult 2.5 mg NEB not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27
Asthma / bronchospasm peds 2.5 mg NEB not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27

Amiodarone

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 150 mg IV not captured standing page 26
Other adult 300 mg IV/IO not captured standing pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26
Other peds 5 mg/kg IV/IO not captured standing pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26

Atropine

IndicationPopulationDoseRouteRepeatStandingSource
Bradycardia adult 1 mg IV/IO not captured standing pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26
Bradycardia peds 0.02 mg/kg IV/IO not captured standing pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26
Nerve agent exposure adult 4–6 mg IV/IO/IM not captured standing page 28
Nerve agent exposure peds 0.1 mg/kg IV/IO/IM not captured standing page 28

Cefazolin

IndicationPopulationDoseRouteRepeatStandingSource
Trauma / hemorrhage adult 2 g IV not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27
Trauma / hemorrhage peds 150–1000 mg IV not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27

Ceftriaxone

IndicationPopulationDoseRouteRepeatStandingSource
Trauma / hemorrhage adult 2 g IV not captured standing pages 11, 13, 15, 17, 19, 21, 23, 25, 27
Trauma / hemorrhage peds 300–1700 mg IV not captured standing pages 11, 13, 15, 17, 19, 21, 23, 25, 27

Dextrose

IndicationPopulationDoseRouteRepeatStandingSource
Hypoglycemia adult 25 g IV not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25
Hypoglycemia peds 2.5 g IV not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25

Diazepam

IndicationPopulationDoseRouteRepeatStandingSource
Procedural sedation adult 5–10 mg IV not captured standing page 27

Diltiazem

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 20 mg IV not captured standing page 26

Diphenhydramine

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 50 mg IV/IO/IM not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25
Anaphylaxis peds 15 mg IV/IO/IM not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25

Epinephrine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 0.3 mg IM not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27
Other peds 0.01 mg/kg IV/IO not captured standing pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26
Stridor peds 5 mg NEB not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25

Fentanyl

IndicationPopulationDoseRouteRepeatStandingSource
Mild to moderate pain adult 50–100 mcg IV/IN not captured standing pages 9, 13, 15, 17, 19, 21, 23, 25, 27
Mild to moderate pain peds 10–20 mcg IV/IN not captured standing pages 9, 13, 15, 17, 19, 21, 23, 25, 27

Glucagon

IndicationPopulationDoseRouteRepeatStandingSource
Hypoglycemia adult 1 mg IM not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27
Hypoglycemia peds 0.5 mg IM not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27

Hydroxocobalamin

IndicationPopulationDoseRouteRepeatStandingSource
Cyanide poisoning adult 5000 mg IV/IO not captured standing page 29
Cyanide poisoning peds 250 mg IV/IO not captured standing page 29

Ibuprofen

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 600 mg PO not captured standing pages 13, 15, 17, 19, 21, 23, 25, 27
Other peds 80–300 mg PO not captured standing pages 13, 15, 17, 19, 21, 23, 25, 27

Ipratropium

IndicationPopulationDoseRouteRepeatStandingSource
Asthma / bronchospasm adult 500 mcg NEB not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27
Asthma / bronchospasm peds 500 mcg NEB not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 27

Ketamine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 200–400 mg IM not captured standing page 27
Mild to moderate pain adult 10–20 mg IV/IO not captured standing pages 25, 27
Mild to moderate pain adult 30–50 mg IN not captured standing pages 15, 17, 19, 21, 23, 25, 27
Mild to moderate pain peds 10 mg IV/IO not captured standing pages 25, 27
Mild to moderate pain peds 10–30 mg IN not captured standing pages 15, 17, 19, 21, 23, 25, 27
Procedural sedation adult 75–150 mg IV not captured standing page 27

Ketorolac

IndicationPopulationDoseRouteRepeatStandingSource
Mild to moderate pain adult 15 mg IV/IM not captured standing pages 21, 23, 25, 27
Mild to moderate pain peds 10.5 mg IV/IM not captured standing pages 21, 23, 25, 27

Lidocaine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 100 mg IV/IO not captured standing pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26
Other peds 1 mg/kg IV/IO not captured standing pages 8, 10, 12, 14, 16, 18, 20, 22, 24, 26

Methylprednisolone

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 125 mg IV/IO/IM not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25
Anaphylaxis peds 10 mg IV/IO/IM not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25

Midazolam

IndicationPopulationDoseRouteRepeatStandingSource
Procedural sedation adult 1–5 mg not captured not captured standing page 27
Seizure adult 10 mg IM not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25
Seizure adult 5 mg IV not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25

Morphine

IndicationPopulationDoseRouteRepeatStandingSource
Mild to moderate pain adult 4–5 mg IV/IO/IM not captured standing pages 17, 19, 21, 23, 25, 27
Mild to moderate pain peds 2 mg IV/IO/IM not captured standing pages 17, 19, 21, 23, 25, 27

Naloxone

IndicationPopulationDoseRouteRepeatStandingSource
Opioid overdose adult 2 mg IV/IM not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 26
Opioid overdose peds 0.5–2 mg IV/IM not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25, 26

Nerve Agent Antidote Kit

IndicationPopulationDoseRouteRepeatStandingSource
Nerve agent exposure adult 2 to 3 IM not captured standing page 28
Nerve agent exposure peds 1 IM not captured standing page 28

Prednisone

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 50 mg PO not captured standing pages 23, 25, 27
Anaphylaxis peds 50 mg PO not captured standing pages 23, 25, 27

Racemic Epinephrine

IndicationPopulationDoseRouteRepeatStandingSource
Stridor peds 11.25 mg NEB not captured standing pages 9, 11, 13, 15, 17, 19, 21, 23, 25

Verapamil

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 5 mg IV not captured standing page 26